维普期刊资源整合服务平台（V6.5）

177篇 您的检索式：作者名="Seidman AD"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer显示文摘	Seidman AD Oshaughnessy J Misset JL	2002	Oncologist2002，17，6：	1
2	Motorneuropathy due to doeetaxel and paelitaxel显示文摘	Freilieh RJ Balmaceda C Seidman AD	1996	Neurology1996，47，1：	1
3	Randomized phase Ⅲ trial of weekly compared with every-3-week paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of cancer and leukemia group B protocol 9840 显示文摘	Seidman AD Berry D Cirrineione C	2008	J Clin Oncol2008，26，10：	1
4	Phase Ⅱ evaluation of taxotere (RP 56976, NSC 628503) as initial chemotherapy for metastatic breast cancer 显示文摘	Seidman AD Hudis C Crown JPA	1993	Proc Am Soc Clin Oncol1993，12，：	1
5	A pooled analysis of gemcitabine plus docetaxel versus capecitabine plus docetaxel in metastatic breast cancer显示文摘	Seidman AD Chan S Wang J	2014	Oncologist2014，19，5：	1
6	Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer显示文摘	Esteva FJ Seidman AD	2000	Semin Oncol2000，27，611：	1
7	Randomized phase III trialof weekly compared with every-3-wk paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 over expressers and random assignment to trastuzumab or not in HER-2 non over expressers: final results of cancer and leukemia group B protol 9840 显示文摘	Seidman AD Berry D Cirrincione C	2008	J Clin Oncol2008，26，10：	1
8	Gemcitabine as single-agent therapy in the management of advanced breast cancer 显示文摘	Seidman AD	2001	Oncology2001，15，3：	1
9	Comparison of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in metastatic breast cancer显示文摘	Kaptain S Seidman AD Esteva FJ	2000	Mod Pathol2000，13，1：	1
10	Cardiac dysfunction associated with trastuzumab显示文摘	Smith KL Dang C Seidman AD	2006	Expert Opin Drug Saf2006，5，5：	1
11	Gemcitabine as single agent therapy in the management of advanced breast cancer 显示文摘	Seidman AD	2001	Oncology2001，15，3：	1
12	Randomized phase Ⅲ trial of weekly compared with every-3-weeks paclitaxel for Metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpres- sots:final results of cancer and leukemia group B protocol 9840显示文摘	Seidman AD Berry D Cirrincione C	2008	J Clin Oncol2008，26，10：	1
13	CALGB 9840:Phase Ⅲ study of weekly(W) paclitaxel(P) via 1-hour(h) infusion versus standard(S) 3h infusion every third week in the treatment of metastatic breast cancer(MBC),with trastuzumab(T) for HER2 positive MBC and randomized for T in HER2 normal MBC显示文摘	Seidman AD Berry D Cirrincione C	2004	Proc Am Soc Clin Oncol2004，，：	1
14	Transtuzumab in combination with chemotherapy for the treatment of metastatic breast cancer 显示文摘	Fomier M Estera FJ Seidman AD	2000	Semin Oncol2000，27，11：	1
15	Paclitaxel as second and subsequent therapy for metastatic breast cancer:activity independent of prior anthracycline response显示文摘	Seidman AD Reichman BS Grown JP	1995	J Clin Oncol1995，13，5：	1
16	Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer 显示文摘	SEIDMAN AD HUDIS CA ALBANEL J	1998	J Clin Oncol1998，16，10：	1
17	Final report: weekly herceptin and taxol for metastatic breast cancer: analysis of efficacy by HER-2 immunophenotype and gene amplification 显示文摘	Fornier M Esteva F	2000	Proc Am Soc Clin Oncol2000，19，：	1
18	Gemcitabine as single-agent therapy in the management of advanced breast cancer显示文摘	Seidman AD	2001	Oncology2001，15，3：	1
19	Beyond cytotoxic chemotherapy for the first-line treatment of HER2-negative, hormone-insensitive metastatic breast cancer: current status and future opportunities显示文摘	COLIN AK SEIDMAN AD	2008	Clin Breast Cancer2008，8，3：	1
20	HER2 overexprcssion and paclitaxel sensitivity in breast cancer: therapeutic implications显示文摘	Seidman AD Rosen PP	1997	Oncology1997，11，32：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示